Analysis of Mandatory Post-Marketing Surveillance Studies Supports Revised Regulatory Requirements in Korea. [PDF]
Wolter K +7 more
europepmc +1 more source
Real-world safety and effectiveness of alemtuzumab for relapsed or refractory chronic lymphocytic leukaemia: results from postmarketing surveillance in Japan. [PDF]
Sasakura Y, Hatanaka M, Ishizawa K.
europepmc +1 more source
Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan. [PDF]
Kawakami H +3 more
europepmc +1 more source
Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study. [PDF]
Ohtsuki M +8 more
europepmc +1 more source
Comprehensive post-marketing safety evaluation of atezolizumab: A disproportionality analysis based on individual case safety reports in the FAERS. [PDF]
Cui Y +5 more
europepmc +1 more source
Economic Regulation and Its Reform: What Have We Learned? [PDF]
Patricia M. Danzon, Eric L. Keuffel
core
Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis. [PDF]
Han XY +5 more
europepmc +1 more source
Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan. [PDF]
Yuri A +7 more
europepmc +1 more source

